Tuixent Escribà

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Míriam Rosás-Umbert, Jesper Damsgaard Gunst, Marie H. Pahus et al. · Nature Communications · 2022 · 97 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

Lucía Bailón, Anuska Llano, Samandhy Cedeño et al. · Nature Medicine · 2022 · 71 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors

Lander Egaña-Gorroño, Tuixent Escribà, Nicolas Boulanger et al. · PLoS ONE · 2014 · 55 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution

Susana Benet, Oscar Blanch-Lombarte, Erola Ainsua‐Enrich et al. · The Journal of Infectious Diseases · 2022 · 37 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy

Lander Egaña-Gorroño, Estebán Martínez, Bru Cormand et al. · AIDS · 2012 · 35 citations

Medicine, Genetics, Molecular Genetics +17